William Adams is an accomplished and experienced patent attorney, and his primary focus is patent litigation in the biotechnology, pharmaceutical, and medical device fields. William has been involved in numerous disputes on behalf of life sciences and pharmaceutical companies, and is co-chair of both the firm’s Hatch-Waxman and Life Sciences Litigation Practice Groups.
William has extensive experience in U.S. federal district courts regarding pharmaceutical patent litigation involving Abbreviated New Drug Applications under the Hatch-Waxman Act. Moreover, William has been involved in counseling clients under the Biologics Price Competition and Innovation Act (the “BPCIA”). William’s technical training (B.S. in Chemical Engineering & M.S. in Biotechnology), along with his previous experience working as a pharmaceutical development scientist at a leading drug delivery company allows him to quickly understand the technology at issue. William has had success on behalf of his clients in federal district courts, at the ITC, and at the USPTO.
Having spent time as in-house IP counsel, William truly understands the demands, perspectives, and budgets of his clients. That in-house experience has helped William ensure that each matter and case entrusted to him by his clients is handled efficiently and effectively.
University of Alabama, J.D., Editor of the Journal of the Legal Profession
Johns Hopkins University, M.S., Biotechnology
University of Alabama, B.S., Chemical Engineering
State Bar of California
U.S. Court of Appeals for the Federal Circuit
U.S. District Court – Central District of California
U.S. District Court – Northern District of California
U.S. District Court – Southern District of California
U.S. Patent and Trademark Office
Biotech
Aesthetic & Cosmetic Biotechnology
AgBio
Antibodies & Immunology
Biofuels
Biological Manufacturing of Chemicals
Biologics
Diagnostic Tools
Genomics
Industrial Enzymes
Peptides
Personalized Medicine
Stem Cells & Regenerative Medicine
Synthetic Biology & Nanotechnology
Therapeutics
Vaccines
Chemical, Industrial & Materials
Analytical Chemistry
Biochemistry
Chemical Engineering
Cosmetics & Personal Care Products
Food Chemistry
Fuel Cells & Batteries
Oil & Gas
Organic Chemistry
Pharmaceutical Chemistry
Physical Chemistry
Polymers
Consumer Products & Services
Aesthetics & Personal Care Products
Food & Beverage
Sporting Goods & Recreation
Energy
Biodegradable Materials
Bioenergy & Biofuels
Biomass
Clean Technology
Medical Devices & Procedures
Aesthetics & Implants
Biocompatible Polymers & Coatings
Cardiac Rhythm Management
Cardiovascular
Catheters & Probes
Dental Devices
Dermatology
Diagnostics
Drug-Eluting Devices
Embolic Protection
Minimally Invasive & Endoscopic Procedures
Oncology
Ophthalmology & Eye Care
Sleep Apnea
Pharmaceuticals
Antibodies and Immunology
Biological Manufacturing of Chemicals
Biologics
Biosimilars
Diagnostic Tools
Peptides
Personalized Medicine
Stem Cells & Regenerative Medicine
Therapeutics
Vaccines
Advertising, Media & Entertainment Practice
Antitrust & Competition
Appellate Litigation
Covered Business Method (CBM)
Due Diligence
Hatch-Waxman Litigation
Inter Partes Review (IPR)
International Trade Commission (ITC) Disputes
IP Strategy
IP Transactions, Agreements & Venture Capital
Litigation
Patent Litigation
Patent Trial & Appeal Board (PTAB) Trials (Post Grant)
Post-Grant Review (PGR)
Trade Secret
Trade Secret & Employee Mobility Litigation
Trade Secret & Employee Mobility Litigation
Trademark & Brand Protection
Trademark Litigation & Unfair Competition
Trademark Litigation & Unfair Competition
Trademark Trial & Appeal Board (TTAB) Disputes
TTAB Proceedings
Unfair Competition Litigation
- Recognized by The Legal 500 “United States” for Patent Litigation (2024)
- Recognized by The Legal 500 “United States” for Patent Litigation (2023)
- American Chemical Society (ACS)
- American Intellectual Property Law Association (AIPLA)
- American Bar Association (ABA), Intellectual Property Section
- Association of Business Trial Lawyers
